spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Signaling protein PDB id
1yz5
Jmol
Contents
Protein chains
223 a.a. *
Waters ×72
* Residue conservation analysis
PDB id:
1yz5
Name: Signaling protein
Title: The crystal structure of 14-3-3-sigma at 2.8 angstrom resolution
Structure: 14-3-3 protein sigma. Chain: a, b. Synonym: stratifin, epithelial cell marker protein 1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
Biol. unit: Dimer (from PQS)
Resolution:
2.80Å     R-factor:   0.223     R-free:   0.292
Authors: A.Benzinger,G.M.Popowicz,T.A.Holak,H.Hermeking
Key ref:
A.Benzinger et al. (2005). The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Res, 15, 219-227. PubMed id: 15857576 DOI: 10.1038/sj.cr.7290290
Date:
28-Feb-05     Release date:   08-Mar-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P31947  (1433S_HUMAN) -  14-3-3 protein sigma
Seq:
Struc:
248 a.a.
223 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   4 terms 
  Biological process     cell proliferation   15 terms 
  Biochemical function     protein binding     4 terms  

 

 
DOI no: 10.1038/sj.cr.7290290 Cell Res 15:219-227 (2005)
PubMed id: 15857576  
 
 
The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization.
A.Benzinger, G.M.Popowicz, J.K.Joy, S.Majumdar, T.A.Holak, H.Hermeking.
 
  ABSTRACT  
 
Seven different, but highly conserved 14-3-3 proteins are involved in diverse signaling pathways in human cells. It is unclear how the 14-3-3sigma isoform, a transcriptional target of p53, exerts its inhibitory effect on the cell cycle in the presence of other 14-3-3 isoforms, which are constitutively expressed at high levels. In order to identify structural differences between the 14-3-3 isoforms, we solved the crystal structure of the human 14-3-3sigma protein at a resolution of 2.8 Angstroms and compared it to the known structures of 14-3-3zeta and 14-3-3tau. The global architecture of the 14-3-3sigma fold is similar to the previously determined structures of 14-3-3zeta and 14-3-3t: two 14-3-3sigma molecules form a cup-shaped dimer. Significant differences between these 14-3-3 isoforms were detected adjacent to the amphipathic groove, which mediates the binding to phosphorylated consensus motifs in 14-3-3-ligands. Another specificity determining region is localized between amino-acids 203 to 215. These differences presumably select for the interaction with specific ligands, which may explain the different biological functions of the respective 14-3-3 isoforms. Furthermore, the two 14-3-3sigma molecules forming a dimer differ by the spatial position of the ninth helix, which is shifted to the inside of the ligand interaction surface, thus indicating adaptability of this part of the molecule. In addition, 5 non-conserved residues are located at the interface between two 14-3-3sigma proteins forming a dimer and represent candidate determinants of homo- and hetero-dimerization specificity. The structural differences among the 14-3-3 isoforms described here presumably contribute to isoform-specific interactions and functions.
 
  Selected figure(s)  
 
Figure 2.
An overall ribbon plot of the 14-3-3 homodimer. Each monomer consists of nine antiparallel helices and the protein dimerizes in a perfect 2-fold symmetry. The dimer forms a large cup-shaped space between monomers with two phosphopeptide binding sites at its sides. The C-terminal helix of the monomer A (blue) is significantly shifted toward the binding site; chain B is shown in dark-red. (A) a view perpendicular to the helices axis is presented. (B) a view parallel to this axis.
Figure 5.
Ligand recognition by 14-3-3 proteins. (A) Unbound (red) and (blue) are superimposed with the structure of the isoform (green) bound to serotonin N-acetyltransferase (C trace) to indicate the structural diversity of the Ala203 and Asp215 loop area. (B) Structures of (blue) and (red) are overlaid. The molecular surface of the isoform is shown half-transparent. The structure and surface of the phosphopeptide from the 1QJA model is shown in light blue. Non-conserved residues in this area are labeled for the isoform. Significant difference in the Ala203 and Asp215 loop are evident.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Cell Res (2005, 15, 219-227) copyright 2005.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20144150 L.Yasmin, J.L.Veesenmeyer, M.H.Diaz, M.S.Francis, C.Ottmann, R.H.Palmer, A.R.Hauser, and B.Hallberg (2010).
Electrostatic interactions play a minor role in the binding of ExoS to 14-3-3 proteins.
  Biochem J, 427, 217-224.  
19371722 K.Kligys, J.Yao, D.Yu, and J.C.Jones (2009).
14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytes.
  Biochem Biophys Res Commun, 383, 450-454.  
18054234 M.Zannis-Hadjopoulos, W.Yahyaoui, and M.Callejo (2008).
14-3-3 cruciform-binding proteins as regulators of eukaryotic DNA replication.
  Trends Biochem Sci, 33, 44-50.  
18687683 X.Liang, M.B.Butterworth, K.W.Peters, W.H.Walker, and R.A.Frizzell (2008).
An Obligatory Heterodimer of 14-3-3{beta} and 14-3-3{epsilon} Is Required for Aldosterone Regulation of the Epithelial Sodium Channel.
  J Biol Chem, 283, 27418-27425.  
17932789 O.Gileadi, S.Knapp, W.H.Lee, B.D.Marsden, S.Müller, F.H.Niesen, K.L.Kavanagh, L.J.Ball, F.von Delft, D.A.Doyle, U.C.Oppermann, and M.Sundström (2007).
The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins.
  J Struct Funct Genomics, 8, 107-119.  
17433535 S.N.Quayle, and M.D.Sadar (2007).
14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.
  Cancer Lett, 254, 137-145.  
16678438 A.Aitken (2006).
14-3-3 proteins: a historic overview.
  Semin Cancer Biol, 16, 162-172.  
16678437 A.K.Gardino, S.J.Smerdon, and M.B.Yaffe (2006).
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms.
  Semin Cancer Biol, 16, 173-182.  
16698281 D.Lodygin, and H.Hermeking (2006).
Epigenetic silencing of 14-3-3sigma in cancer.
  Semin Cancer Biol, 16, 214-224.  
16697662 H.Hermeking, and A.Benzinger (2006).
14-3-3 proteins in cell cycle regulation.
  Semin Cancer Biol, 16, 183-192.  
16607644 J.M.Lau, C.Wu, and A.J.Muslin (2006).
Differential role of 14-3-3 family members in Xenopus development.
  Dev Dyn, 235, 1761-1776.  
16697215 M.H.Lee, and G.Lozano (2006).
Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
  Semin Cancer Biol, 16, 225-234.  
16368691 M.Lalle, A.M.Salzano, M.Crescenzi, and E.Pozio (2006).
The Giardia duodenalis 14-3-3 protein is post-translationally modified by phosphorylation and polyglycylation of the C-terminal tail.
  J Biol Chem, 281, 5137-5148.  
17085597 X.Yang, W.H.Lee, F.Sobott, E.Papagrigoriou, C.V.Robinson, J.G.Grossmann, M.Sundström, D.A.Doyle, and J.M.Elkins (2006).
Structural basis for protein-protein interactions in the 14-3-3 protein family.
  Proc Natl Acad Sci U S A, 103, 17237-17242.
PDB codes: 2bq0 2br9 2btp 2c23 2c63 2c74
16511572 Y.Jin, M.S.Dai, S.Z.Lu, Y.Xu, Z.Luo, Y.Zhao, and H.Lu (2006).
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.
  EMBO J, 25, 1207-1218.  
15857578 D.Lodygin, and H.Hermeking (2005).
The role of epigenetic inactivation of 14-3-3sigma in human cancer.
  Cell Res, 15, 237-246.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.